{ "model": { "rank": 4249, "code": "thing-q169960", "model_id": "vr.tr.oxytocin", "name": "oxytocin", "purpose": "Enable an agent to recognise oxytocin, assess its molecular and functional state, and determine which handling, research or therapeutic actions require further evidence or authorisation.", "family": "Thing Registry", "category": "Physical world and living systems", "status": "research-draft", "kind": "thing", "plane": "PHY", "domain": "PHY.MAT", "industry": "", "version": "", "url": "/models/thing/q169960/", "tier": 2, "score": 77, "payload": { "layer": "wikidata", "aliases": [], "aliasCount": 0, "merged": 0, "knownIn": 77, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q169960", "url": "https://www.wikidata.org/wiki/Q169960", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-09T19:48:04Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 27, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a087b5-92b1-74c1-b4b6-49f5ecde2881\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: oxytocin\nSense to describe: (none recorded)\nDomain code: PHY.MAT\nAlso known as: (none)\n\n\nContext for this batch of 695 things:\n# Batch 004: 1001 registe", "usd": 0, "recall": true }, "codex": { "seconds": 66.3, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a087b5-92bf-75e1-9669-fc705c4477a8\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: oxytocin\nRegistry id: vr.tr.oxytocin\nPlane / domain: PHY / PHY.MAT\nRegistry definition: (none recorded)\nNames folded into this entry: (none)\n\n\nContex" } } }, "metaModel": { "id": "THING-Q169960", "registryId": "vr.tr.oxytocin", "name": "oxytocin", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "PHY.MAT" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q169960/", "model": { "registry_id": "vr.tr.oxytocin", "name": "oxytocin", "purpose": "Enable an agent to recognise oxytocin, assess its molecular and functional state, and determine which handling, research or therapeutic actions require further evidence or authorisation.", "definition": "Oxytocin is a cyclic nonapeptide hormone synthesized chiefly by hypothalamic neurons that promotes uterine contraction and milk ejection and also acts as a signaling molecule within the brain.", "scope_statement": "This model owns oxytocin as a peptide substance, including endogenous and manufactured instances, molecular identity, biological activity, sample quality and constraints on use; it distinguishes the substance from medicines containing it and physiological systems responding to it.", "in_scope": [ "Molecular identity, peptide sequence, stereochemistry and disulfide connectivity", "Endogenous or manufactured provenance and relationships to precursor processing", "Oxytocin receptor activity and context-dependent biological effects", "Sample composition, concentration, potency, degradation and storage state", "Substance identifiers, grade and evidence governing permissible use" ], "out_of_scope": [ "Complete anatomy and function of hypothalamic, pituitary, reproductive or mammary systems", "Finished medicinal product formulations, packaging and marketing authorisations", "Patient-specific prescribing, dosing and obstetric management", "Manufacturing equipment and complete synthesis processes", "Independent models of vasopressin, oxytocin analogues and receptor proteins", "General theories of attachment, trust or social behaviour" ], "distinguishing_features": [ "Identify the mature nonapeptide with sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly, a Cys1-Cys6 disulfide bridge and an amidated C terminus; sequence alone does not establish correct stereochemistry or conformation.", "Distinguish mature oxytocin from its precursor and associated neurophysin using molecular identity and processing evidence.", "Distinguish oxytocin from vasopressin and modified analogues through sequence and structural analysis; related receptor activity is insufficient identification.", "Distinguish the oxytocin component from a medicine or laboratory preparation containing buffers, preservatives, counterions or other substances.", "Treat endogenous and synthetic origin as provenance differences rather than separate molecular identities when structural equivalence is demonstrated." ], "characteristics": [ { "name": "Molecular identity", "kind": "category", "unit_or_values": "Sequence, residue stereochemistry, terminal modifications and disulfide connectivity", "why_it_matters": "Separates mature oxytocin from precursors, analogues and structurally altered material." }, { "name": "Chemical registry identity", "kind": "relation", "unit_or_values": "Verified CAS, PubChem and applicable EC records, with represented chemical form", "why_it_matters": "Supports cross-source matching without conflating the peptide with salts or preparations." }, { "name": "Origin and processing", "kind": "category", "unit_or_values": "Endogenous, chemically synthesised, other documented production route or unknown", "why_it_matters": "Determines which processing, impurity and traceability evidence is relevant." }, { "name": "Biological location", "kind": "relation", "unit_or_values": "Species, tissue, cellular or extracellular compartment, and sampling time", "why_it_matters": "Prevents measurements from different biological compartments being treated as interchangeable." }, { "name": "Amount or concentration", "kind": "measurement", "unit_or_values": "mol, mg, mol/L or mass/volume, with matrix, method and uncertainty", "why_it_matters": "Makes quantities interpretable and distinguishes substance amount from activity." }, { "name": "Biological potency", "kind": "measurement", "unit_or_values": "Assay-defined activity or IU per stated amount or volume, with reference standard", "why_it_matters": "Prevents an unsupported conversion between peptide mass and functional activity." }, { "name": "Purity and impurity profile", "kind": "measurement", "unit_or_values": "Method-specific purity percentage and identified impurity concentrations", "why_it_matters": "Determines whether reported material represents intact oxytocin adequately for its intended use." }, { "name": "Physical and stability state", "kind": "state", "unit_or_values": "Dry or dissolved form; temperature, pH where applicable, exposure history and degradation assessment", "why_it_matters": "Connects handling conditions to evidence of retained identity and activity." }, { "name": "Receptor response", "kind": "measurement", "unit_or_values": "Assay-specific binding or response parameters, with receptor, species and experimental conditions", "why_it_matters": "Separates measured receptor engagement from inferred whole-organism effects." }, { "name": "Grade and use eligibility", "kind": "state", "unit_or_values": "Documented grade, applicable specification, jurisdiction and permitted-use status", "why_it_matters": "Prevents research material or unverified samples from being treated as eligible for clinical use." } ], "affordances": [ "Match a substance record or sample to oxytocin using structural and analytical evidence.", "Compare concentration and potency results after checking matrix, units, assay and reference standard.", "Trace endogenous processing or manufactured lot provenance and identify missing evidence.", "Assess whether documented storage and quality results support continued use for a stated purpose.", "Evaluate receptor and physiological claims within their species, compartment and experimental context.", "Route a proposed use to the relevant research, medicinal-product or clinical model when additional controls apply." ] }, "sources": [], "structure": { "bundles": [ { "id": "peptide-identity", "name": "Peptide identity", "description": "Establishes which molecular entity an oxytocin record or sample represents.", "rationale": "Related peptides, precursors and preparations cannot be distinguished reliably by name or biological activity alone.", "layers": [ { "id": "mature-molecule", "name": "Mature molecule", "description": "Records the structural features required to identify mature oxytocin.", "findings": [ { "id": "structural-identity-evidence", "name": "Structural identity evidence", "description": "Requires evidence for sequence, stereochemistry, terminal amidation and disulfide connectivity.", "questions": [ { "text": "Which analytical evidence confirms the expected sequence, stereochemistry, C-terminal amidation and Cys1-Cys6 disulfide connectivity?", "kind": "measurement", "id": "structural-identity-evidence-q01" }, { "text": "Does the material contain mature oxytocin, precursor material, an analogue or a mixture of these?", "kind": "boundary", "id": "structural-identity-evidence-q02" } ] } ] }, { "id": "registered-form", "name": "Registered form", "description": "Connects identifiers to the exact peptide form and separates it from its surrounding preparation.", "findings": [ { "id": "identifier-and-form-alignment", "name": "Identifier and form alignment", "description": "Checks whether identifiers and reported quantities refer to oxytocin itself or to a salt, hydrated material or formulated preparation.", "questions": [ { "text": "Which verified chemical identifiers describe the represented oxytocin form?", "kind": "provenance", "id": "identifier-and-form-alignment-q01" }, { "text": "Are counterions, water and excipients included in the reported mass or modelled separately?", "kind": "boundary", "id": "identifier-and-form-alignment-q02" } ] } ] } ] }, { "id": "origin-and-biological-location", "name": "Origin and biological location", "description": "Describes how oxytocin arose and where a biological observation applies.", "rationale": "Molecular equivalence does not make production histories or measurements from different biological compartments equivalent.", "layers": [ { "id": "production-and-processing", "name": "Production and processing", "description": "Distinguishes endogenous precursor processing from manufactured production.", "findings": [ { "id": "origin-traceability", "name": "Origin traceability", "description": "Connects mature peptide to documented biological processing or a manufactured lot.", "questions": [ { "text": "What evidence establishes endogenous origin or the production route and lot of manufactured oxytocin?", "kind": "provenance", "id": "origin-traceability-q01" }, { "text": "For endogenous material, which precursor and processing evidence supports identification of the mature peptide?", "kind": "definition", "id": "origin-traceability-q02" } ] } ] }, { "id": "compartment-and-sampling", "name": "Compartment and sampling", "description": "Anchors biological measurements to species, location, timing and sample treatment.", "findings": [ { "id": "biological-measurement-context", "name": "Biological measurement context", "description": "Records the context needed to interpret an oxytocin measurement without extending it to unmeasured compartments.", "questions": [ { "text": "Which species, tissue or fluid, sampling time and physiological context does the measurement represent?", "kind": "measurement", "id": "biological-measurement-context-q01" }, { "text": "What evidence supports any proposed inference from the sampled compartment to central or other unmeasured oxytocin activity?", "kind": "boundary", "id": "biological-measurement-context-q02" }, { "text": "How were collection, extraction and sample preservation validated for the measurement method?", "kind": "provenance", "id": "biological-measurement-context-q03" } ] } ] } ] }, { "id": "receptor-activity-and-effects", "name": "Receptor activity and effects", "description": "Connects oxytocin exposure to measured receptor responses and bounded physiological claims.", "rationale": "Chemical identity, receptor activity and whole-organism outcomes are different kinds of evidence.", "layers": [ { "id": "receptor-engagement", "name": "Receptor engagement", "description": "Records binding and functional responses in a specified receptor system.", "findings": [ { "id": "assay-specific-response", "name": "Assay-specific response", "description": "Qualifies activity claims by receptor identity, species, concentration and assay endpoint.", "questions": [ { "text": "Which receptor, species, expression system and endpoint were used to measure oxytocin activity?", "kind": "measurement", "id": "assay-specific-response-q01" }, { "text": "What concentration-response and comparator evidence distinguishes oxytocin receptor activity from activity at related receptors?", "kind": "measurement", "id": "assay-specific-response-q02" } ] } ] }, { "id": "physiological-interpretation", "name": "Physiological interpretation", "description": "Separates measured tissue or organism responses from broader causal interpretations.", "findings": [ { "id": "effect-and-context", "name": "Effect and context", "description": "Requires contextual evidence for claims concerning uterine activity, milk ejection or behavioural outcomes.", "questions": [ { "text": "Which effect was measured directly, and under what reproductive state, exposure route and timing?", "kind": "measurement", "id": "effect-and-context-q01" }, { "text": "Does the evidence establish causation, association or only a proposed mechanism for the claimed outcome?", "kind": "boundary", "id": "effect-and-context-q02" }, { "text": "Which population or experimental limits prevent generalising the result to other physiological or social contexts?", "kind": "boundary", "id": "effect-and-context-q03" } ] } ] } ] }, { "id": "sample-quality-and-stability", "name": "Sample quality and stability", "description": "Assesses how much intact, active oxytocin a sample contains and whether that state has been maintained.", "rationale": "A label or nominal concentration does not establish peptide integrity, potency or suitability after handling.", "layers": [ { "id": "content-purity-and-potency", "name": "Content, purity and potency", "description": "Separates chemical amount, analytical purity and biological activity.", "findings": [ { "id": "quantitative-quality-evidence", "name": "Quantitative quality evidence", "description": "Links each quality result to its method, matrix, reference standard and uncertainty.", "questions": [ { "text": "What methods quantify intact oxytocin and distinguish it from related peptides or degradation products?", "kind": "measurement", "id": "quantitative-quality-evidence-q01" }, { "text": "Which reference standard supports the potency value and any conversion between mass and international units?", "kind": "provenance", "id": "quantitative-quality-evidence-q02" }, { "text": "Which impurity limits and assay acceptance criteria apply to the stated grade and intended use?", "kind": "boundary", "id": "quantitative-quality-evidence-q03" } ] } ] }, { "id": "storage-and-degradation", "name": "Storage and degradation", "description": "Relates sample form and exposure history to validated stability evidence.", "findings": [ { "id": "retained-integrity", "name": "Retained integrity", "description": "Assesses stability for the actual dry material or solution rather than assigning a universal shelf life to oxytocin.", "questions": [ { "text": "What temperature, light, pH where applicable, container and handling history has this material experienced?", "kind": "provenance", "id": "retained-integrity-q01" }, { "text": "Which stability data support retained identity and potency for this form over the proposed storage or use period?", "kind": "measurement", "id": "retained-integrity-q02" }, { "text": "Does an excursion or observed degradation require retesting, quarantine or disposal under the applicable procedure?", "kind": "action", "id": "retained-integrity-q03" } ] } ] } ] }, { "id": "use-eligibility-and-handling", "name": "Use eligibility and handling", "description": "Determines what a particular oxytocin material is documented as suitable for and where further decisions belong.", "rationale": "Research reagent identity does not establish medicinal suitability, and substance-level evidence cannot determine patient-specific administration.", "layers": [ { "id": "grade-and-regulatory-context", "name": "Grade and regulatory context", "description": "Connects the material to applicable specifications and jurisdiction-specific use constraints.", "findings": [ { "id": "documented-use-status", "name": "Documented use status", "description": "Requires evidence for claimed grade and eligibility, with finished-product authorisation represented separately.", "questions": [ { "text": "Which certificate, specification or pharmacopoeial standard supports the claimed oxytocin grade?", "kind": "provenance", "id": "documented-use-status-q01" }, { "text": "Which jurisdiction and intended use determine the applicable requirements, and which apply to the finished product instead of the substance?", "kind": "boundary", "id": "documented-use-status-q02" } ] } ] }, { "id": "handling-and-action-boundaries", "name": "Handling and action boundaries", "description": "Uses preparation-specific hazard evidence and establishes when a specialised model must govern an action.", "findings": [ { "id": "evidence-gated-actions", "name": "Evidence-gated actions", "description": "Connects proposed handling or use to documented hazards, material suitability and appropriate decision authority.", "questions": [ { "text": "Which current safety data and applicable hazard classification cover this exact oxytocin material or preparation?", "kind": "provenance", "id": "evidence-gated-actions-q01" }, { "text": "What handling, exposure-response and disposal procedures apply to its concentration and physical form?", "kind": "action", "id": "evidence-gated-actions-q02" }, { "text": "Does the proposed action require a medicinal-product, clinical or research-protocol model before it can proceed?", "kind": "action", "id": "evidence-gated-actions-q03" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This describes the oxytocin molecule; endogenous and synthetic denote origin, not different molecular species.", "Identifiers and structural properties are recalled without source verification; current pharmacopoeial requirements and product-specific regulatory details need checking.", "Claims about trust, bonding, or therapeutic psychiatric effects require careful qualification; behavioral effects depend on context, and peripheral concentrations do not straightforwardly establish brain activity." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Endogenous oxytocin", "Synthetic oxytocin" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "CAS Registry Number", "value_or_pattern": "50-56-6", "note": "Identifies oxytocin; salts and pharmaceutical preparations require additional specification." }, { "scheme": "Molecular formula", "value_or_pattern": "C43H66N12O12S2", "note": "Formula of the oxytocin molecule, excluding counterions and water of hydration." }, { "scheme": "Amino-acid sequence", "value_or_pattern": "CYIQNCPLG-NH2", "note": "Nine residues with a disulfide bond between cysteines at positions 1 and 6 and an amidated C-terminus." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "United States Pharmacopeia-National Formulary, issued by the United States Pharmacopeial Convention, provides quality monographs for oxytocin and oxytocin injection.", "European Pharmacopoeia, published by the European Directorate for the Quality of Medicines & Health, provides an oxytocin quality monograph.", "World Health Organization international biological reference standards support the expression and comparison of oxytocin potency." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "An endogenous signal supporting uterine contractions during childbirth.", "An endogenous signal causing milk ejection through contraction of mammary myoepithelial cells.", "A pharmaceutical active ingredient used for induction or augmentation of labor.", "A pharmaceutical active ingredient used to prevent or treat postpartum bleeding associated with inadequate uterine contraction.", "A research reagent for studying peptide receptors, neuroendocrine signaling, and social behavior." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Molar mass", "typical_range": "Approximately 1007.19", "unit": "g/mol" }, { "quantity": "Peptide chain length", "typical_range": "9", "unit": "amino-acid residues" }, { "quantity": "Intramolecular disulfide bonds", "typical_range": "1", "unit": "bond per molecule" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Excessive pharmaceutical stimulation of the uterus can compromise fetal oxygenation and cause serious maternal injury.", "Rapid intravenous administration can cause hypotension and cardiovascular disturbances.", "Prolonged administration, particularly with excessive electrolyte-free fluid, can contribute to water intoxication and hyponatremia.", "Peptide degradation during unsuitable storage can reduce pharmaceutical potency.", "Confusing biological potency units with mass or solution volume can cause medication errors." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Approved indications, formulations, labeling, and administration requirements differ between national medicines regulators.", "Applicable pharmacopoeial specifications and product storage requirements depend on jurisdiction and formulation." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Vasopressin", "difference": "A related nonapeptide with a different amino-acid sequence, principally associated with water balance and vascular effects." }, { "name": "Carbetocin", "difference": "A distinct synthetic oxytocin analogue with structural modifications and a longer duration of action." }, { "name": "Prolactin", "difference": "A protein hormone that principally supports milk production; oxytocin triggers milk ejection." }, { "name": "Oxytocin injection", "difference": "A finished pharmaceutical formulation containing oxytocin plus a vehicle and potentially other ingredients, rather than the substance alone." }, { "name": "Oxytocin receptor", "difference": "The receptor protein that responds to oxytocin, rather than the peptide ligand." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of oxytocin this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Which authoritative identifier records should anchor this entry, and how should salts, hydration and peptide-content reporting be represented without creating duplicate substance models?", "Which analytical and biological reference methods provide sufficiently comparable oxytocin measurements across manufactured material and biological matrices?", "Which form-specific physical constants, solubility and degradation data are reliable, and should decomposition behaviour replace melting or boiling values where those values are not meaningful?", "Which current pharmacopoeial specifications, hazard classifications and occupational exposure provisions apply to the intended grades and jurisdictions?", "How strongly do available studies support inferences between peripheral measurements, central activity and behavioural outcomes, and where must those links remain unresolved?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 19, "questions": 34 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "chemical substance or material", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a oxytocin, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an agent to recognise oxytocin, assess its molecular and functional state, and determine which handling, research or therapeutic actions require further evidence or authorisation.", "characteristics": { "substance": "material", "origin": "natural", "agency": "inert", "mobility": "varies" }, "whatYouCanDoWithIt": [ "observed and measured", "consumed or used up" ], "distinguishingFeatures": [ "Described in 77 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a oxytocin, and on what evidence are they told apart?" ], "whatItIsMadeOf": "matter you can touch", "physicalCharacter": [ "Mobility varies between examples.", "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state", "use it up, and then need more of it" ], "howItIsRecognised": [ "Not recognisable by sight in any reliable way. Appearance varies with grade, form and additives; identification is by label, by documentation, or by assay." ], "relatedModels": [], "standing": "Described in 77 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one oxytocin from another, and a oxytocin from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a oxytocin sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a oxytocin from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "form-and-composition", "name": "Form, composition and condition", "description": "What a oxytocin is made of, what shape and size it takes, and what state it is in.", "rationale": "A physical thing can be measured, and a model that cannot record its measurements cannot support any decision that depends on them.", "layers": [ { "id": "form-and-dimensions", "name": "Form and dimensions", "description": "Shape, size, mass and the ranges these take across examples.", "findings": [ { "id": "measurable-dimensions", "name": "Measurable dimensions and their units", "description": "The quantities worth recording and the units they are recorded in.", "questions": [ { "id": "measurable-dimensions-q01", "text": "What identifies and describes the dimensions of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "measurable-dimensions-q02", "text": "Who or what asserted this about the dimensions of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "measurable-dimensions-q03", "text": "What may an agent decide or do once the dimensions of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "material-and-composition", "name": "Material and composition", "description": "Materials, parts and how they are put together.", "findings": [ { "id": "parts-and-materials", "name": "Parts and materials", "description": "What a oxytocin is built from and which parts are replaceable.", "questions": [ { "id": "parts-and-materials-q01", "text": "What identifies and describes the composition of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "parts-and-materials-q02", "text": "Who or what asserted this about the composition of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "parts-and-materials-q03", "text": "What may an agent decide or do once the composition of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "condition-and-integrity", "name": "Condition and integrity", "description": "Wear, damage, health and the difference between working and broken.", "findings": [ { "id": "condition-assessment", "name": "Condition, damage and health", "description": "How the condition of a oxytocin is judged and by whom.", "questions": [ { "id": "condition-assessment-q01", "text": "What identifies and describes the condition of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "condition-assessment-q02", "text": "Who or what asserted this about the condition of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "condition-assessment-q03", "text": "What may an agent decide or do once the condition of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "place-and-movement", "name": "Place and movement", "description": "Where a oxytocin is, how it got there and where it may go (varies).", "rationale": "A thing that can move needs its position recorded with a time, or every later claim about it is about a place it has left.", "layers": [ { "id": "location-and-placement", "name": "Location and placement", "description": "Position, containment and the reference frame the position is given in.", "findings": [ { "id": "position-and-frame", "name": "Position, container and reference frame", "description": "Where a oxytocin is, and what that position is measured against.", "questions": [ { "id": "position-and-frame-q01", "text": "What identifies and describes the location of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "position-and-frame-q02", "text": "Who or what asserted this about the location of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "position-and-frame-q03", "text": "What may an agent decide or do once the location of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "movement-and-transfer", "name": "Movement and transfer", "description": "How a oxytocin is carried, installed or relocated.", "findings": [ { "id": "movement-events", "name": "Movement events and constraints", "description": "What counts as a movement, what records it and what limits it.", "questions": [ { "id": "movement-events-q01", "text": "What identifies and describes the movement of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "movement-events-q02", "text": "Who or what asserted this about the movement of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "movement-events-q03", "text": "What may an agent decide or do once the movement of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a oxytocin passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a oxytocin between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a oxytocin, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a oxytocin is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "use-and-operation", "name": "Use and operation", "description": "What can be done with a oxytocin and what it takes to do it.", "rationale": "An agent that can recognise a thing but not act on it has only half a model.", "layers": [ { "id": "intended-use", "name": "Intended use and function", "description": "What a oxytocin is for, and what it is used for anyway.", "findings": [ { "id": "function-and-purpose", "name": "Function, purpose and misuse", "description": "The function a oxytocin performs and the uses that fall outside it.", "questions": [ { "id": "function-and-purpose-q01", "text": "What identifies and describes the use of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "function-and-purpose-q02", "text": "Who or what asserted this about the use of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "function-and-purpose-q03", "text": "What may an agent decide or do once the use of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "handling-and-procedure", "name": "Handling and procedure", "description": "The steps, skills and tools involved in using a oxytocin.", "findings": [ { "id": "procedures-and-skills", "name": "Procedures, skills and required tools", "description": "What an agent needs before it can act on a oxytocin at all.", "questions": [ { "id": "procedures-and-skills-q01", "text": "What identifies and describes handling a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "procedures-and-skills-q02", "text": "Who or what asserted this about handling a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "procedures-and-skills-q03", "text": "What may an agent decide or do once handling a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "supply-and-consumption", "name": "Supply and consumption", "description": "Quantities, rates and what running out means.", "findings": [ { "id": "consumption-and-stock", "name": "Consumption, stock and replenishment", "description": "How much of a oxytocin there is and how fast it goes.", "questions": [ { "id": "consumption-and-stock-q01", "text": "What identifies and describes the supply of a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "consumption-and-stock-q02", "text": "Who or what asserted this about the supply of a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "consumption-and-stock-q03", "text": "What may an agent decide or do once the supply of a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "composition-and-identity", "name": "Composition, grade and chemical identity", "description": "What oxytocin is made of and how pure the thing in hand is.", "rationale": "Grade decides what a substance may be used for, so a model that records only the name cannot support any decision about use.", "layers": [ { "id": "chemical-identity", "name": "Chemical identity", "description": "Formula, structure and the registry numbers that name it unambiguously.", "findings": [ { "id": "identity-record", "name": "Identity and registry numbers", "description": "What identifies this substance across suppliers and regulators.", "questions": [ { "id": "identity-record-q01", "text": "What formula, structure and registry identifiers name oxytocin unambiguously?", "kind": "definition" }, { "id": "identity-record-q02", "text": "Which related substances share a name in common use but not an identifier?", "kind": "boundary" } ] } ] }, { "id": "grade-and-impurities", "name": "Grade, purity and impurities", "description": "The specification a batch meets and what else is in it.", "findings": [ { "id": "specification", "name": "Specification and assay", "description": "How purity is stated and measured, and which impurities matter.", "questions": [ { "id": "specification-q01", "text": "What grades of oxytocin exist, how is purity assayed, and which impurities are limited?", "kind": "measurement" }, { "id": "specification-q02", "text": "Which use requires which grade, and what happens when a lower grade is substituted?", "kind": "action" } ] } ] } ] }, { "id": "properties-and-behaviour", "name": "Properties and behaviour", "description": "How oxytocin behaves under conditions an agent can measure or change.", "rationale": "Physical constants are the part of a substance model that transfers between contexts, and each needs its unit and its conditions.", "layers": [ { "id": "physical-constants", "name": "Physical constants", "description": "Values that hold for the pure substance, with their conditions.", "findings": [ { "id": "constants-record", "name": "Constants and conditions", "description": "The quantities worth recording and the state they apply in.", "questions": [ { "id": "constants-record-q01", "text": "What are the defining physical constants of oxytocin, in what units and under what conditions?", "kind": "measurement" }, { "id": "constants-record-q02", "text": "Which of these values change with grade or form rather than being fixed?", "kind": "boundary" } ] } ] }, { "id": "stability-and-reactivity", "name": "Stability and reactivity", "description": "What it reacts with, degrades into, and how it is stored.", "findings": [ { "id": "incompatibilities", "name": "Incompatibilities and degradation", "description": "What must not meet it, and what it becomes over time.", "questions": [ { "id": "incompatibilities-q01", "text": "What is oxytocin incompatible with, and what does it degrade into under storage?", "kind": "definition" }, { "id": "incompatibilities-q02", "text": "What storage and handling does that require, and who is competent to do it?", "kind": "action" } ] } ] } ] }, { "id": "hazard-and-regulation", "name": "Hazard classification and regulation", "description": "How oxytocin can harm, and what the law says about holding and moving it.", "rationale": "A substance model without its hazard class and its regulatory identity is unusable in exactly the situations that matter.", "layers": [ { "id": "hazard-class", "name": "Hazard classification", "description": "Classified hazards, exposure limits and protective measures.", "findings": [ { "id": "classified-hazards", "name": "Classified hazards and limits", "description": "The classification, the scheme it belongs to, and the limits set.", "questions": [ { "id": "classified-hazards-q01", "text": "How is oxytocin classified for hazard, under which scheme, and what exposure limits apply?", "kind": "definition" }, { "id": "classified-hazards-q02", "text": "What protection does handling require, and what must an agent refuse to do without it?", "kind": "action" } ] } ] }, { "id": "regulatory-identity", "name": "Regulatory identity and control", "description": "Registration, restriction and transport rules by jurisdiction.", "findings": [ { "id": "controls", "name": "Controls and jurisdiction", "description": "Where it is restricted and what the restriction attaches to.", "questions": [ { "id": "controls-q01", "text": "Which registrations, restrictions or transport rules cover oxytocin, and where?", "kind": "provenance" }, { "id": "controls-q02", "text": "Does the control attach to the substance, its concentration, or its intended use?", "kind": "boundary" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a oxytocin came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a oxytocin and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a oxytocin is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a oxytocin, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a oxytocin, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a oxytocin is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 9, "layers": 20, "findings": 22, "questions": 60 } } } }